Patent ID: 11944666
Assignee: REGENERON PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of treating recurrent pericarditis comprising administering subcutaneously to a patient in need of treatment, an interleukin-1 receptor-Fc fusion protein at a therapeutic dose,
wherein the interleukin-1 receptor-Fc fusion protein is dimeric and comprises an extracellular domain of IL-1R1, an extracellular domain of IL-1R accessory protein (IL-1RAcP), and an Fc portion of a human immunoglobulin,
wherein the extracellular domain of IL-1R1 comprises an amino acid sequence with at least 99% identity to SEQ ID NO: 4, and
wherein the extracellular domain of IL-1RAcP comprises an amino acid sequence with at least 99% identity to SEQ ID NO: 3.